Cardiovascular safety of rosiglitazone

Lancet. 2007 Jun 16;369(9578):1995-1996. doi: 10.1016/S0140-6736(07)60824-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Myocardial Infarction / chemically induced*
  • Randomized Controlled Trials as Topic
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone